XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]        
Net sales $ 1,814 $ 1,915 $ 5,190 $ 5,370
Cost of products sold 1,048 1,115 3,026 3,324
Gross profit 766 800 2,164 2,046
Selling and administrative expenses 301 311 899 854
Advertising costs 215 206 566 523
Research and development costs 32 35 93 100
Loss on divestiture 240 0 240 0
Pension settlement charge 0 0 171 0
Goodwill, trademark and other asset impairments 0 445 0 445
Interest expense 22 24 69 69
Other (income) expense, net (2) 24 3 54
Earnings (losses) before income taxes (42) (245) 123 1
Income tax expense (benefit) 8 (36) 52 21
Net earnings (losses) (50) (209) 71 (20)
Less: Net earnings attributable to noncontrolling interests 1 2 7 7
Net earnings (losses) attributable to Clorox $ (51) $ (211) $ 64 $ (27)
Net earnings (losses) per share attributable to Clorox        
Basic net earnings (losses) per share (in dollars per share) $ (0.41) $ (1.71) $ 0.52 $ (0.22)
Diluted net earnings (losses) per share (in dollars per share) $ (0.41) $ (1.71) $ 0.52 $ (0.22)
Weighted average shares outstanding (in thousands)        
Basic (in shares) 124,249 123,649 124,133 123,512
Diluted (in shares) 124,249 123,649 124,721 123,512
Comprehensive income (loss) $ 154 $ (205) $ 409 $ (39)
Less: Total comprehensive income attributable to noncontrolling interests 1 2 7 7
Total comprehensive income (loss) attributable to Clorox $ 153 $ (207) $ 402 $ (46)